205 related articles for article (PubMed ID: 20195391)
1. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
[TBL] [Abstract][Full Text] [Related]
2. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
3. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
4. CCN3 suppresses TGF-β1-induced extracellular matrix accumulation in human mesangial cells in vitro.
Liu HF; Liu H; Lv LL; Ma KL; Wen Y; Chen L; Liu BC
Acta Pharmacol Sin; 2018 Feb; 39(2):222-229. PubMed ID: 28858296
[TBL] [Abstract][Full Text] [Related]
5. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
6. Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy.
Riser BL; Najmabadi F; Garchow K; Barnes JL; Peterson DR; Sukowski EJ
Am J Pathol; 2014 Nov; 184(11):2908-21. PubMed ID: 25193594
[TBL] [Abstract][Full Text] [Related]
7. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
[TBL] [Abstract][Full Text] [Related]
8. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
9. CCN3: a novel anti-fibrotic treatment in end-stage renal disease?
Leask A
J Cell Commun Signal; 2012 Jun; 6(2):115-6. PubMed ID: 22421928
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis.
Riser BL; Bhagavathula N; Perone P; Garchow K; Xu Y; Fisher GJ; Najmabadi F; Attili D; Varani J
J Cell Commun Signal; 2012 Jun; 6(2):97-105. PubMed ID: 22648571
[TBL] [Abstract][Full Text] [Related]
11. Yin and Yang revisited: CCN3 as an anti-fibrotic therapeutic?
Leask A
J Cell Commun Signal; 2015 Mar; 9(1):97-8. PubMed ID: 25700690
[TBL] [Abstract][Full Text] [Related]
12. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
[TBL] [Abstract][Full Text] [Related]
13. Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.
Akashi S; Nishida T; El-Seoudi A; Takigawa M; Iida S; Kubota S
J Cell Commun Signal; 2018 Mar; 12(1):245-252. PubMed ID: 29129024
[TBL] [Abstract][Full Text] [Related]
14. Diabetic Foot Ulcer as a Cause of Significant Decline in the Renal Function Among South Indian Population With Type 2 Diabetes: Role of TGF-β1 and CCN Family Proteins.
Smina TP; Rabeka M; Viswanathan V
Int J Low Extrem Wounds; 2019 Dec; 18(4):354-361. PubMed ID: 31304816
[TBL] [Abstract][Full Text] [Related]
15. Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer.
Riser BL; Barnes JL; Varani J
J Cell Commun Signal; 2015 Dec; 9(4):327-39. PubMed ID: 26698861
[TBL] [Abstract][Full Text] [Related]
16. The advance of CCN3 in fibrosis.
Yin H; Liu N; Zhou X; Chen J; Duan L
J Cell Commun Signal; 2023 Dec; 17(4):1219-1227. PubMed ID: 37378812
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis.
Cooker LA; Peterson D; Rambow J; Riser ML; Riser RE; Najmabadi F; Brigstock D; Riser BL
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F157-65. PubMed ID: 17376761
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
19. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
